PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
89.93%
Revenue growth above 1.5x AR's 36.71%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
309.76%
Gross profit growth above 1.5x AR's 58.84%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
971.26%
EBIT growth above 1.5x AR's 23.98%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
971.26%
Operating income growth above 1.5x AR's 23.98%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
663.07%
Net income growth 1.25-1.5x AR's 537.98%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
661.70%
EPS growth 1.25-1.5x AR's 508.93%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
654.26%
Diluted EPS growth 1.25-1.5x AR's 508.93%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
-0.08%
Share reduction while AR is at 6.80%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
1.24%
Diluted share reduction more than 1.5x AR's 6.52%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
23.17%
Maintaining or increasing dividends while AR cut them. John Neff might see a strong edge in shareholder returns.
96.20%
OCF growth above 1.5x AR's 63.12%. David Dodd would confirm a clear edge in underlying cash generation.
255.98%
FCF growth above 1.5x AR's 62.96%. David Dodd would verify if the firm’s strategic investments yield superior returns.
192.62%
10Y revenue/share CAGR under 50% of AR's 3969.45%. Michael Burry would suspect a lasting competitive disadvantage.
161.01%
5Y revenue/share CAGR at 50-75% of AR's 240.53%. Martin Whitman would worry about a lagging mid-term growth trajectory.
95.23%
3Y revenue/share CAGR at 50-75% of AR's 139.88%. Martin Whitman would question if the firm lags behind competitor innovations.
21.95%
10Y OCF/share CAGR under 50% of AR's 1087.40%. Michael Burry would worry about a persistent underperformance in cash creation.
366.46%
5Y OCF/share CAGR above 1.5x AR's 243.40%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
59.30%
3Y OCF/share CAGR under 50% of AR's 291.33%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
152.43%
Net income/share CAGR at 50-75% of AR's 224.59%. Martin Whitman might question if the firm’s product or cost base lags behind.
210.19%
Below 50% of AR's 14173.82%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
333.70%
Below 50% of AR's 1578.41%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-51.25%
Negative equity/share CAGR over 10 years while AR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-35.07%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-37.58%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-75.07%
Cut dividends over 10 years while AR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
245.88%
Dividend/share CAGR of 245.88% while AR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
174.91%
3Y dividend/share CAGR of 174.91% while AR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
6.23%
AR growth is negative/stable vs. AR's 38.32%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
No Data
No Data available this quarter, please select a different quarter.
0.15%
Asset growth well under 50% of AR's 2.96%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
24.37%
BV/share growth above 1.5x AR's 2.54%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-15.45%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-5.15%
We cut SG&A while AR invests at 30.58%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.